Article info

Original research
Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial

Authors

  1. Correspondence to Professor Jon Amund Kyte; jonky{at}ous-hf.no
View Full Text

Citation

Andresen NK, Røssevold AH, Quaghebeur C, et al
Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial

Publication history

  • Accepted December 27, 2023
  • First published January 19, 2024.
Online issue publication 
January 19, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.